2Hiusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? [J]. Contact Derm, 2004, 51(5-6): 297-310.
3Andersen KE, Hjorth N, Menn6 T. The baboon syndrome: systemically-induced allergic contact dermatitis [J]. Contact Derm, 1984, 10(2):97-100.
4Wolf R, Orion E, Matz H. The baboon syndrome or intertriginous drug eruption: a report of eleven cases and a second look at its pathomechanism [J]. Dermatol Online J, 2003, 9(3):2.
5Ozkaya E. Current understanding of Baboon syndrome [J]. Expert Rev Dermatol, 2009, 4(2): 163-175.
6Atsushi M, Hisashi K, Yukari O, et al. A new proposal for a clinical-oriented subclassification of baboon syndrome and a review of baboon syndrome [J]. Asian Pac J Allergy Immunol, 2011, 29(2):150-160.
7Winnicki M, Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug-related intertrinous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions [J]. Am J Clin Dermatol, 2011, 12(3):171-180.
8Tan SC, Tan JW. Symmetrical drug-related intertriginous and flexural exanthema [J]. Curr Opin Allergy Clin Immunol, 2011, 11(4):313-318.
9Elmariah SB, Cheung W, Wang N, et al. Systemic drug-related intertriginous and flexuralexanthema (SDRIFE) [J]. Dermatol Online J, 2009, 15(8):3.
10Pontoppidan TJ, Ira MH. Drug-elicited systemic allergic (contact) dermatitis-update and possible pathomechanisms [J]. Contact Derm, 2008, 59(4): 195-202.
